-
Rasagiline (Azilect, Azipron) is an
irreversible inhibitor of
monoamine oxidase-B used as a
monotherapy to
treat symptoms in
early Parkinson's disease...
- imipramine, desipramine),
monoamine oxidase inhibitors (MAOIs) (e.g.,
rasagiline),
serotonin antagonists and
reuptake inhibitors (SARIs) (e.g., nefazodone)...
- both
monoamine oxidase (MAO) B
inhibitors l-deprenyl (Selegiline) and
rasagiline (Azilect) as anti-Parkinson
drugs which possess neuroprotective activities...
- B
propargyl amine inhibitor rasagiline (N-propargyl-1-R-aminoindan, Azilect((R))). The oral
bioavailability of
rasagiline is 35%, it
reaches T(max) after...
-
combines the
mechanisms of
action of
older drugs like
rivastigmine and
rasagiline into a
single molecule. In
addition to its
neuroprotective properties...
-
conjugated by glucuronyltransferase. A
newer anti-Parkinson MAO-B inhibitor,
rasagiline,
metabolizes into 1(R)-aminoindan,
which has no amphetamine-like characteristics...
-
developed in the
context of anti-Parkinsonian
drugs as a
metabolite of
rasagiline and as a tool to be used in psychotherapy.
Deaths related to
their toxic...
-
treatment of Parkinson's disease. A MAO-B
inhibitor such as
selegiline or
rasagiline can
prevent this from happening.[citation needed] It can also be found...
-
Nefopam Nikethamide Nomifensine O-2172
Oxaprotiline PNU-99,194 PRC200-SS
Rasagiline Rauwolscine Rubidium chloride Setazindol Tametraline Tandamine Thiopropamine...
-
Nefopam Nikethamide Nomifensine O-2172
Oxaprotiline PNU-99,194 PRC200-SS
Rasagiline Rauwolscine Rubidium chloride Setazindol Tametraline Tandamine Thiopropamine...
